Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,17 USD | -1,36% | -2,69% | +11,86% |
Métier
Nombre d'employés: 224
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
T-Cell Therapies
100,0
%
| 85 | 100,0 % | 0 | 100,0 % | -99,85% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 85 | 100,0 % | 0 | 100,0 % | -99,85% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Lynn Seely
CEO | Chief Executive Officer | 65 | 01/05/21 |
Charles Newton
DFI | Director of Finance/CFO | 53 | 01/02/21 |
Stephen Hill
COO | Chief Operating Officer | 53 | 01/06/19 |
Gary Lee
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/22 |
Richard D. Goold
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/04/19 |
Ellen Rose
IRC | Investor Relations Contact | - | 01/04/21 |
Matthew Lang
LAW | General Counsel | 48 | 05/07/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Lynn Seely
CEO | Chief Executive Officer | 65 | 01/05/21 |
Robert Nelsen
BRD | Director/Board Member | 60 | 01/09/18 |
Otis Brawley
BRD | Director/Board Member | 64 | 01/04/21 |
William Rieflin
BRD | Director/Board Member | 64 | 01/05/20 |
Richard Klausner
CEO | Chief Executive Officer | 72 | 01/06/18 |
Director/Board Member | 63 | 01/08/18 | |
Hans Bishop
BRD | Director/Board Member | 59 | 01/08/18 |
Elizabeth Nabel
BRD | Director/Board Member | 72 | 01/04/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 254 936 784 | 206 999 293 ( 81,20 %) | 0 | 81,20 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
CERo Therapeutics Holdings, Inc.
3,35% | 499 999 | 3,35% | 1 534 997 $ |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+11,86% | 553 M | |
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,74 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |
- Bourse
- Actions
- Action LYEL
- Société Lyell Immunopharma, Inc.